Neurocognitive late effects most commonly follow treatment of malignancies that require central nervous system (CNS)-directed therapies, such as cranial radiation, systemic therapy with high-dose methotrexate or cytarabine, or with intrathecal chemotherapy. Children with brain tumors or acute lymphoblastic leukemia are most likely to be affected. Risk factors for the development of neurocognitive side effects are female gender, young age at the time of treatment, supratentorial tumor location, higher radiation dose, treatment with both cranial radiation and chemotherapy (systemic or intrathecal), and lower socioeconomic status.[1,2,3,4,5]
Survival rates have increased over recent decades for children with brain tumors; however, long-term cognitive effects due to their illness and associated treatments are emerging. In childhood and adolescent brain tumor survivors, tumor site, treatment of hydrocephalus with a shunt, paralysis, postsurgery mutism, auditory difficulties, or history of a stroke have emerged as risk factors for adverse neurocognitive effects.[6,7,8,9]
Cranial radiation therapy has been associated with the highest risk of long-term cognitive morbidity particularly in younger children. There is an established dose-response relationship with those getting higher-dose cranial radiation therapy consistently performing more poorly on intellectual measures.
The negative impact of radiation treatment has been characterized by changes in intelligence quotient (IQ) scores, which have been noted to drop about 2 to 5 years after diagnosis with an attenuation of the decline 5 to 10 years afterward, followed by stabilization of the IQ scores 20 to 40 years after diagnosis.[11,12,13]
The decline over time is typically reflective of the child's failure to acquire new abilities or information at a rate similar to peers, rather than a progressive loss of skills and knowledge. Affected children may experience information-processing deficits resulting in academic difficulties and are prone to problems with receptive and expressive language, attention span, and visual and perceptual motor skills.[12,14,15,16]
These changes in intellectual functioning may be partially explained by radiation-induced or chemotherapy-induced reduction of normal white matter volume as evaluated through magnetic resonance imaging (MRI).[17,18,19] Using lower doses of radiation and more targeted volumes have demonstrated improved results in neurocognitive effects of therapy.[8,20]